Liver disease US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Liver disease. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Liver disease US Medical PG Question 1: A 60-year-old rock musician presents to the office because he has been feeling increasingly tired for the past 6 months. He has a history of intravenous drug use and alcohol abuse. He states that he feels quite tired, but he otherwise has no complaints. Physical examination is noncontributory. His laboratory values are normal other than moderately elevated liver enzymes. Which of the following additional tests should you order first?
- A. Hepatitis C virus antibodies (Correct Answer)
- B. Hepatitis B surface antigen
- C. Hepatitis E virus-specific IgM antibodies
- D. Hepatitis D virus-specific IgG antibody
- E. Hepatitis A virus-specific IgM antibodies
Liver disease Explanation: ***Hepatitis C virus antibodies***
- The patient's history of **intravenous drug use** and **chronic fatigue** with **elevated liver enzymes** strongly suggests chronic viral hepatitis, with hepatitis C being the most common blood-borne infection in persons with IVDU history.
- **Hepatitis C** is the **most prevalent chronic viral hepatitis** in the United States among persons with history of injection drug use, with transmission efficiency via needle sharing being very high.
- Hepatitis C often has a **long asymptomatic phase** (decades) before symptoms like fatigue and liver damage become apparent, making antibody testing the appropriate initial screen.
- While both HBV and HCV should ultimately be screened in this patient, **HCV prevalence is significantly higher** in the IVDU population, making it the priority initial test.
*Hepatitis B surface antigen*
- While **hepatitis B** can also be transmitted via intravenous drug use and cause chronic liver disease, **hepatitis C is more prevalent** in persons with IVDU history in the United States.
- **HBsAg** is used to detect active hepatitis B infection and should also be ordered, but given resource constraints and the clinical context, **anti-HCV is the higher-yield initial test**.
- Many IVDU patients have been vaccinated against HBV, further reducing its likelihood compared to HCV (for which no vaccine exists).
*Hepatitis E virus-specific IgM antibodies*
- **Hepatitis E** is typically transmitted via the **fecal-oral route** (contaminated water) and usually causes **acute, self-limiting hepatitis**, not chronic insidious fatigue and liver enzyme elevation in a Western patient.
- **IgM antibodies** would indicate an acute infection, which is less likely given the 6-month duration of symptoms.
- HEV rarely causes chronic infection except in immunocompromised patients.
*Hepatitis D virus-specific IgG antibody*
- **Hepatitis D** requires an existing **hepatitis B infection** to replicate (it's a satellite virus), meaning you would first need to confirm chronic hepatitis B before testing for HDV.
- While HDV can cause severe liver disease and is transmitted via blood exposure, it's not the initial test to pursue without evidence of HBV co-infection.
*Hepatitis A virus-specific IgM antibodies*
- **Hepatitis A** is transmitted via the **fecal-oral route** and causes an **acute, self-limiting infection** with complete resolution, rarely leading to chronic liver disease or persistent fatigue over 6 months.
- **IgM antibodies** are indicative of acute infection, which contradicts the chronic nature of the patient's symptoms.
- HAV does not cause chronic hepatitis.
Liver disease US Medical PG Question 2: A 59-year-old woman comes to the physician for a routine health maintenance examination. She feels well. She has systemic lupus erythematosus and hypertension. She does not drink alcohol. Her current medications include lisinopril and hydroxychloroquine. She appears malnourished. Her vital signs are within normal limits. Examination shows a soft, nontender abdomen. There is no ascites or hepatosplenomegaly. Serum studies show:
Total bilirubin 1.2 mg/dL
Alkaline phosphatase 60 U/L
Alanine aminotransferase 456 U/L
Aspartate aminotransferase 145 U/L
Hepatitis A IgM antibody negative
Hepatitis A IgG antibody positive
Hepatitis B surface antigen positive
Hepatitis B surface antibody negative
Hepatitis B envelope antigen positive
Hepatitis B envelope antibody negative
Hepatitis B core antigen IgM antibody negative
Hepatitis B core antigen IgG antibody positive
Hepatitis C antibody negative
Which of the following is the most appropriate treatment for this patient?
- A. Pegylated interferon alpha therapy
- B. Tenofovir therapy (Correct Answer)
- C. Referral to a liver transplantation center
- D. Reassurance and follow-up
- E. Lamivudine therapy
Liver disease Explanation: ***Tenofovir therapy***
- This patient has **chronic hepatitis B** with evidence of **active viral replication** (positive HBsAg, HBeAg, and elevated liver enzymes), indicating a need for antiviral treatment.
- **Tenofovir** is a highly effective and well-tolerated oral antiviral agent for chronic hepatitis B, suitable for initial therapy.
*Pegylated interferon alpha therapy*
- While an option for chronic hepatitis B, **pegylated interferon alpha** has more significant side effects and is generally avoided in patients with **systemic lupus erythematosus (SLE)** due to the risk of exacerbating the autoimmune condition.
- It also requires subcutaneous injections and has a lower rate of HBeAg seroconversion compared to nucleos(t)ide analogs in many patient populations.
*Referral to a liver transplantation center*
- This patient currently shows **elevated liver enzymes** but no immediate signs of **decompensated liver disease** (e.g., ascites, encephalopathy, variceal bleeding) or severe liver failure that would warrant urgent transplantation.
- Treatment with antiviral medication is the first step to prevent progression to end-stage liver disease.
*Reassurance and follow-up*
- The patient has **elevated transaminases** and markers of **active viral replication** (positive HBeAg), indicating ongoing liver injury and potential progression to cirrhosis.
- Simply observing the patient without treatment would be inappropriate and could lead to irreversible liver damage.
*Lamivudine therapy*
- **Lamivudine** is an older nucleos(t)ide analog for hepatitis B that has a significantly **higher rate of drug resistance** compared to newer agents like tenofovir.
- It is generally not recommended as a first-line treatment due to its resistance profile.
Liver disease US Medical PG Question 3: A 27-year-old man presents to the emergency department with loss of consciousness. The patient was brought in 20 minutes ago by the supervisor at a homeless shelter who found him passed out next to a bottle of acetaminophen. The patient has a past medical history of HIV, hepatitis C, IV drug abuse, alcohol abuse, suicide attempt, and constipation. He takes methadone daily but is notably non-compliant with his anti-retroviral therapy. His temperature is 104°F (40°C), blood pressure is 85/40 mmHg, pulse is 180/min, respirations are 18/min, and oxygen saturation is 90% on room air. The patient is started on IV fluids, N-acetylcysteine, and 100% oxygen. Blood cultures are obtained, and lab work is sent off. The patient is then started on broad spectrum antibiotics and given norepinephrine. Repeat vitals demonstrate hypotension and tachycardia. Serum toxicology returns and is positive for alcohol. The patient is transferred to the medicine floor and managed further. Two days later, the patient's vitals have improved. Repeat lab values are ordered and return as follows:
Hemoglobin: 11 g/dL
Hematocrit: 30%
Leukocyte count: 6,500 cells/mm^3 with normal differential
Platelet count: 245,000/mm^3
Serum:
Na+: 138 mEq/L
Cl-: 100 mEq/L
K+: 4.1 mEq/L
HCO3-: 22 mEq/L
BUN: 30 mg/dL
Glucose: 145 mg/dL
Creatinine: 1.4 mg/dL
Ca2+: 9.6 mg/dL
AST: 1,440 U/L
ALT: 1,350 U/L
Which of the following is the best explanation for this patient’s laboratory abnormalities?
- A. Antibiotic use
- B. Chronic viral infection
- C. Alcohol abuse
- D. Previous hypotension
- E. Toxic liver metabolite (Correct Answer)
Liver disease Explanation: ***Toxic liver metabolite***
- The patient experienced an **acetaminophen overdose**, which leads to the production of **NAPQI**, a toxic metabolite. This causes significant **hepatocellular injury**, reflected by the extremely elevated AST and ALT levels.
- The elevated AST and ALT indicate severe **acute liver damage**, which is characteristic of acetaminophen toxicity. The initial presentation with **loss of consciousness**, subsequent **hypotension**, and a history of **suicide attempt** (with a bottle of acetaminophen found nearby) strongly support this etiology.
*Antibiotic use*
- While some antibiotics can cause **drug-induced liver injury**, the exceptionally high AST and ALT levels (over 1000 U/L) are more indicative of a **massive hepatocellular insult** like acetaminophen toxicity, rather than a typical antibiotic reaction.
- Antibiotic-induced liver damage is usually less severe and often presents with a more **cholestatic pattern** or a different enzyme elevation profile.
*Chronic viral infection*
- The patient has a history of **hepatitis C** and **HIV**, which can cause chronic liver inflammation and elevated transaminases. However, these conditions typically result in **persistently elevated but less dramatically high** AST and ALT levels.
- The acute presentation with **loss of consciousness** and the finding of an acetaminophen bottle point to an acute event rather than a chronic viral exacerbation.
*Alcohol abuse*
- Chronic alcohol abuse can cause **alcoholic hepatitis** and elevated liver enzymes. However, alcoholic hepatitis typically results in an **AST:ALT ratio of 2:1 or greater**, and the values are usually in the hundreds, not in the thousands as seen here.
- While serum toxicology was positive for alcohol, the **extreme transaminase elevation** is more consistent with a acute toxic injury, such as acetaminophen overdose, rather than acute on chronic alcoholic liver disease.
*Previous hypotension*
- **Ischemic hepatitis**, or "shock liver," can occur due to severe hypotension, leading to a rise in transaminases. However, the AST and ALT levels in ischemic hepatitis often **peak within 24-48 hours** and then fall rapidly.
- While the patient was hypotensive, the context of the acetaminophen overdose provides a more specific and potent cause for the observed **massive and sustained liver enzyme elevation**.
Liver disease US Medical PG Question 4: A 56-year-old woman is brought to the emergency department by her family with altered mental status. Her husband says that she complained of fever, vomiting, and abdominal pain 2 days ago. She has a history of long-standing alcoholism and previous episodes of hepatic encephalopathy. Current vital signs include a temperature of 38.3°C (101°F), blood pressure of 85/60 mm Hg, pulse of 95/min, and a respiratory rate 30/min. On physical examination, the patient appears ill and obtunded. She is noted to have jaundice, a palpable firm liver, and massive abdominal distension with shifting dullness. Which of the following is the best initial step in management of this patient's condition?
- A. Empiric antibiotics (Correct Answer)
- B. Diagnostic paracentesis
- C. Large volume paracentesis
- D. Intravenous albumin
- E. Non-selective beta-blockers
Liver disease Explanation: ***Empiric antibiotics***
- This patient presents with **altered mental status**, **fever**, **hypotension (85/60 mm Hg)**, **tachypnea**, and **massive ascites** in the setting of **cirrhosis**, indicating **suspected spontaneous bacterial peritonitis (SBP) with septic shock**.
- In a **hemodynamically unstable patient** with suspected SBP, **empiric antibiotics** (typically a third-generation cephalosporin like ceftriaxone or cefotaxime) should be initiated **immediately** without waiting for diagnostic paracentesis results.
- Current **AASLD and EASL guidelines** emphasize that antibiotic therapy should not be delayed in critically ill patients, as early treatment significantly reduces mortality in SBP.
- Diagnostic paracentesis should still be performed urgently but should **not delay antibiotic administration** in this unstable patient.
*Diagnostic paracentesis*
- While **diagnostic paracentesis** is the gold standard for confirming SBP and should be performed promptly, it is not the **best initial step** in a hemodynamically unstable patient.
- In this critically ill patient with septic shock, obtaining ascitic fluid can be done **simultaneously with** or **immediately after** starting antibiotics, but antibiotics take priority.
- If the patient were stable, diagnostic paracentesis before antibiotics would be appropriate to guide therapy.
*Large volume paracentesis*
- **Large volume paracentesis** is indicated for symptomatic relief of tense ascites causing respiratory compromise, not as an initial step in suspected infection.
- In the setting of suspected SBP, only diagnostic paracentesis (50-100 mL) is needed initially, not large volume removal.
*Intravenous albumin*
- **Intravenous albumin** is given as adjunctive therapy in SBP patients with **renal dysfunction** (creatinine >1 mg/dL, BUN >30 mg/dL) or **hypotension** to prevent hepatorenal syndrome.
- While this patient may benefit from albumin, it is not the **initial step**—antibiotics and fluid resuscitation take priority.
- Albumin is typically given at 1.5 g/kg within 6 hours and 1 g/kg on day 3.
*Non-selective beta-blockers*
- **Non-selective beta-blockers** (propranolol, nadolol) are used for **primary and secondary prophylaxis of variceal bleeding** in portal hypertension.
- They are **contraindicated** in patients with **hypotension** (BP 85/60 mm Hg), **sepsis**, or **SBP**, as they can worsen hemodynamic instability.
- Recent studies suggest beta-blockers may be harmful in patients with refractory ascites or SBP.
Liver disease US Medical PG Question 5: A 55-year-old patient who immigrated from the Middle East to the United States 10 years ago presents to the emergency department because of excessive weakness, abdominal discomfort, and weight loss for the past 10 months. He has had type 2 diabetes mellitus for 10 years for which he takes metformin. He had an appendectomy 12 years ago in his home country, and his postoperative course was not complicated. He denies smoking and drinks alcohol socially. His blood pressure is 110/70 mm Hg, pulse is 75/min, and temperature is 37.1°C (98.7°F). On physical examination, the patient appears exhausted, and his sclerae are yellowish. A firm mass is palpated in the right upper abdominal quadrant. Abdominal ultrasonography shows liver surface nodularity, splenomegaly, and increased diameter of the portal vein. Which of the following is the most common complication of this patient condition?
- A. Hepatopulmonary syndrome
- B. Ascites (Correct Answer)
- C. Hepatic encephalopathy
- D. Hepatorenal syndrome
- E. Hepatic osteodystrophy
Liver disease Explanation: ***Ascites***
- The patient presents with classic signs of **portal hypertension** (splenomegaly, increased portal vein diameter, liver surface nodularity suggesting cirrhosis), and **ascites** is the most common and often the earliest major complication.
- The presence of **abdominal discomfort** and an **RUQ mass** could be related to severe liver disease and its complications, including fluid accumulation or an underlying liver malignancy often associated with cirrhosis.
*Hepatopulmonary syndrome*
- This involves **intrapulmonary vascular dilatations** in the setting of liver disease leading to oxygenation defects, typically marked by platypnea and orthodeoxia, which are not described here.
- While a complication of **cirrhosis**, it is less common than ascites and typically presents with respiratory symptoms not highlighted in this case.
*Hepatic encephalopathy*
- Characterized by **neuropsychiatric symptoms** due to the accumulation of toxins (e.g., ammonia) that the liver cannot detoxify.
- The patient's presentation mainly focuses on physical weakness, abdominal issues, and jaundice, without mention of confusion, asterixis, or altered mental status.
*Hepatorenal syndrome*
- This is a form of **functional renal failure** that occurs in patients with advanced liver disease, presenting with rapidly progressive azotemia due to severe splanchnic vasodilation.
- It is a **later and more severe complication** of liver failure, and while possible, ascites is typically seen much earlier and more frequently.
*Hepatic osteodystrophy*
- This refers to a group of **metabolic bone disorders** (osteoporosis, osteomalacia) that can occur in chronic liver disease.
- While it can manifest as bone pain, it is not a direct or immediate complication of portal hypertension and would not explain the acute abdominal findings.
More Liver disease US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
